Delivery Order 36C26122D0071-36C26124N0045
- Not listed
- The Department of Veterans Affairs, Veterans Integrated Service Network 2 (VISN 2), awarded a delivery order to Roche Diagnostics Corporation on October 1, 2024, for reagents, supplies, and consumables supporting a Roche-manufactured COBAS 6800/8800 laboratory instrument. This firm fixed-price delivery order, valued at $45,712.48, is scheduled for completion by September 30, 2025, and will be performed at the contractor's facility in Castleton, Indiana. The award was made without set-aside...
- Roche Diagnostics Corporation received a $33,561.68 firm fixed-price delivery order from Veterans Integrated Service Network (VISN) 10, a component of the Department of Veterans Affairs, for Roche Diagnostic brand reagents and consumables supplies. The award, announced on March 1, 2026, is scheduled for completion by February 28, 2027, and will be performed at the contractor's facility in Castleton, Indiana. This is a competitive award with no set-aside designation, reflecting open competition...
- Roche Diagnostics Corporation was awarded a delivery order valued at $173,287.16 by Veterans Integrated Service Network (VISN) 21, a civilian component of the Department of Veterans Affairs, for COBAS 6800 reagents and supplies. This firm fixed-price contract, awarded on October 1, 2024, with an ultimate completion date of September 30, 2025, represents a child contract under a larger indefinite delivery vehicle. The contract involves no set-aside designation and performance will occur at...
- This delivery order was awarded to Roche Diagnostics Corporation on October 1, 2024, for the supply of diagnostic reagents and related products to Veterans Integrated Service Network 6 (VISN 6), a component of the Department of Veterans Affairs. The contract carries a ceiling value of $4,014.20 under a firm fixed-price pricing structure with no set-aside designation, indicating open competition. The place of performance is located in Castleton, Indiana, with an ultimate completion date of...
- Roche Diagnostics Corporation was awarded a delivery order valued at $186,088.66 by Veterans Integrated Service Network 6 (VISN 6) on October 1, 2023, for roche reagents and supplies. This firm fixed-price contract, which was not issued under a set-aside designation, has an ultimate completion date of September 30, 2024, and will be performed in Castleton, Indiana. The award represents a child order under VISN 6's larger indefinite delivery contract with Roche Diagnostics, which carries a...
- The Department of Veterans Affairs, Veterans Integrated Service Network 10, awarded a delivery order to Roche Diagnostics Corporation for Roche COBAS 6800 reagents, consumables, and controls, with an ultimate completion date of June 30, 2026. This firm fixed-price delivery order, valued at approximately $5.2 million, represents an extension of the contractor's existing supply agreement for critical laboratory diagnostic equipment and related supplies. The contract was awarded without set-aside...
- The Department of Veterans Affairs' Veterans Integrated Service Network 23 awarded Roche Diagnostics Corporation a delivery order valued at $190,494.82 on October 11, 2024, for microbiology reagents during the base period, with an ultimate completion date of September 30, 2025. This firm fixed-price contract, which includes a deobligation component, will be performed in Castleton, Indiana. The award carries no set-aside designation and represents the government's procurement of essential...
- Roche Diagnostics Corporation received a firm fixed-price delivery order valued at approximately $5.97 million from Veterans Integrated Service Network 7 (VISN 7), a civilian component of the Department of Veterans Affairs, for the supply of reagents. The contract, awarded on September 1, 2023, extends through August 31, 2028, and will be performed in Castleton, Indiana. This delivery order operates as a child contract under the General Services Administration's Critical Analyzers, Laboratory...
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostic solutions, has been awarded a $685,337.42 delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 8 for performance in Castleton, Indiana. The contract, awarded October 1, 2025, with completion targeted for April 30, 2026, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued as a child contract under Roche Diagnostics' existing...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 16, awarded a delivery order contract to Roche Diagnostics Corporation on October 16, 2024, for the supply of reagents and related diagnostic materials. This firm fixed-price delivery order, valued at $194,832.96 with completion targeted by November 15, 2026, represents a child contract under a larger indefinite delivery vehicle. The work will be performed in Castleton, Indiana. No small business set-aside was applied...
- 36C26122D0071Indefinite Delivery Contract
- 36C26122D0071-36C26124N0045Delivery Order
The Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21), awarded a delivery order valued at $216,158.41 to Roche Diagnostics Corporation for COBAS 6800 reagents and supplies. This firm fixed-price delivery order, issued on October 1, 2023, with completion targeted for September 30, 2024, supports laboratory diagnostic capabilities at the performance location in Castleton, Indiana. The award was made through open competition without set-aside designation, reflecting standard federal procurement practices for specialized medical diagnostic supplies. This delivery order represents a child contract under a larger indefinite delivery vehicle with VISN 21, which maintains a $2.5 million indefinite delivery contract with Roche Diagnostics for histology staining services extending through September 2030. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, serves as a primary supplier of advanced diagnostic equipment and reagents across the federal healthcare system, including the Department of Veterans Affairs, Defense Health Agency, and other civilian federal medical entities. The COBAS 6800 molecular diagnostic analyzer is a core component of Roche's federal healthcare portfolio, with the company maintaining extensive contracting relationships across multiple VISNs for reagents, supplies, and associated testing services that support laboratory operations at VA medical facilities nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($30k) | 3/10/26 | |
| Not listed | Not listed | $246.1k | 10/1/23 |